{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:30:58Z","timestamp":1790087458309,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Indiana University Department of Pathology and Laboratory Medicine"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.humpath.2019.04.012","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T02:11:34Z","timestamp":1556849494000},"page":"27-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Plasmacytoid\/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients"],"prefix":"10.1016","volume":"90","author":[{"given":"Carmen M.","family":"Perrino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Eble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Sui","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumeal D.","family":"Whaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Hashemi-Sadraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Francesa","family":"Monn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hristos Z.","family":"Kaimakliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elhaam","family":"Bandali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Grignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2019.04.012_bb0005","series-title":"World Health Organization classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer","author":"Moch","year":"2016"},{"issue":"18.e","key":"10.1016\/j.humpath.2019.04.012_bb0010","first-page":"15","article-title":"Contemporary bladder cancer: variant histology may be a significant driver of disease","volume":"33","author":"Monn","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0015","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.urology.2013.12.035","article-title":"Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes","volume":"83","author":"Kaimakliotis","year":"2014","journal-title":"Urology"},{"issue":"20","key":"10.1016\/j.humpath.2019.04.012_bb0020","first-page":"e23","article-title":"Lymph node metastases in patients with urothelial carcinoma variants: influence of the specific variant on nodal histology","volume":"33","author":"Rice","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0025","first-page":"223","article-title":"Signet-ring cell carcinoma of the urinary bladder","volume":"31","author":"Saphir","year":"1955","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ajcp\/95.1.13","article-title":"Primary signet-ring cell carcinoma of the urinary bladder","volume":"95","author":"Grignon","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0035","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.juro.2008.07.035","article-title":"Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases","volume":"180","author":"Fritsche","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0040","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ijc.25700","article-title":"The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma","volume":"129","author":"Keck","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2019.04.012_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8463731","article-title":"Her2 protein overexpression and gene amplification in plasmacytoid urothelial carcinoma of the urinary bladder","volume":"2016","author":"Kim","year":"2016","journal-title":"Dis Markers"},{"key":"10.1016\/j.humpath.2019.04.012_bb0050","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.humpath.2014.02.023","article-title":"Differential expression of gata-3 in urothelial carcinoma variants","volume":"45","author":"Liang","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/modpathol.2010.187","article-title":"E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma","volume":"24","author":"Lim","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0060","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.humpath.2009.01.001","article-title":"Plasmacytoid urothelial carcinoma of the bladder","volume":"40","author":"Lopez-Beltran","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/PAS.0b013e318186c45e","article-title":"Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases","volume":"33","author":"Nigwekar","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0070","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.humpath.2014.02.024","article-title":"Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder","volume":"45","author":"Paner","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0075","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.humpath.2010.11.011","article-title":"Plasmacytoid urothelial carcinoma of the urinary bladder: Clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series","volume":"42","author":"Raspollini","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0080","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/PAS.0b013e318159af9e","article-title":"Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases","volume":"32","author":"Ro","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0085","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/ajcp\/aqx029","article-title":"Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 49 cases","volume":"147","author":"Fox","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0090","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1245\/s10434-012-2709-4","article-title":"Nuclear e-cadherin expression is associated with the loss of membranous e-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladder","volume":"20","author":"Keck","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"891","key":"10.1016\/j.humpath.2019.04.012_bb0095","first-page":"e7","article-title":"Urothelial carcinoma with plasmacytoid variants producing both human chorionic gonadotropin and carbohydrate antigen 19-9","volume":"68","author":"Shimada","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2019.04.012_bb0100","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.eururo.2005.12.047","article-title":"Plasmacytoid urothelial carcinoma of the urinary bladder report of seven new cases","volume":"50","author":"Mai","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.urology.2016.09.053","article-title":"Outcomes following radical cystectomy for plasmacytoid urothelial carcinoma: defining the need for improved local cancer control","volume":"102","author":"Cockerill","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2019.04.012_bb0110","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.humpath.2005.10.002","article-title":"Urothelial carcinoma with rhabdoid features: report of 6 cases","volume":"37","author":"Parwani","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0115","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1440-1827.2000.01135.x","article-title":"Carcinosarcoma with rhabdoid features of the urinary bladder in a 2-year-old girl: possible histogenesis of stem cell origin","volume":"50","author":"Inagaki","year":"2000","journal-title":"Pathol Int"},{"key":"10.1016\/j.humpath.2019.04.012_bb0120","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/S0022-5347(05)65582-6","article-title":"Pure rhabdoid tumor of the bladder","volume":"166","author":"Duvdevani","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0125","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2559.1987.tb01847.x","article-title":"Rhabdoid tumour of the bladder: a histological, ultrastructural and immunohistochemical study","volume":"11","author":"Harris","year":"1987","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2019.04.012_bb0130","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00000478-200007000-00009","article-title":"Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival","volume":"24","author":"Jimenez","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0135","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/modpathol.2014.158","article-title":"Update for the practicing pathologist: the International Consultation on Urologic Disease\u2013European Association of Urology consultation on bladder cancer","volume":"28","author":"Amin","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0140","series-title":"AJCC cancer staging manual","first-page":"757","article-title":"Urinary bladder. In","author":"Bernard","year":"2016"},{"key":"10.1016\/j.humpath.2019.04.012_bb0145","series-title":"College of American Pathologists","article-title":"Protocol for the examination of specimens from patients with carcinoma of the urinary bladder","author":"Amin","year":"2013"},{"key":"10.1016\/j.humpath.2019.04.012_bb0150","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.urolonc.2012.04.009","article-title":"Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital","volume":"31","author":"Shah","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0155","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.juro.2013.05.040","article-title":"The impact of histological reclassification during pathology re-review\u2014evidence of a Will Rogers effect in bladder cancer?","volume":"190","author":"Linder","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0160","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/modpathol.3800559","article-title":"High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants","volume":"19","author":"Perez-Montiel","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0165","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1097\/PAS.0000000000000922","article-title":"Immunohistochemical differentiation of plasmacytoid urothelial carcinoma from secondary carcinoma involvement of the bladder","volume":"41","author":"Borhan","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.04.012_bb0170","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/1066896916653673","article-title":"Cd138 expression is observed in the urothelial epithelium and in various urothelial carcinomas, and cannot be evidence for plasmacytoid urothelial carcinoma","volume":"24","author":"Goto","year":"2016","journal-title":"Int J Surg Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719300772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719300772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:35:48Z","timestamp":1758645348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817719300772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":34,"alternative-id":["S0046817719300772"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2019.04.012","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmacytoid\/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2019.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}